Association of Retinal Neurodegeneration on Optical Coherence Tomography With Dementia: A Population-Based Study
暂无分享,去创建一个
P. Koudstaal | H. Tiemeier | P. Bonnemaijer | Silvan Licher | F. Wolters | J. Colijn | U. Mutlu | M. A. Ikram | C. Klaver | M. Ikram | M. K. Ikram | M. Ikram | Pieter W. M. Bonnemaijer | M. Ikram
[1] Gabriëlle H S Buitendijk,et al. Retinal neurodegeneration and brain MRI markers: the Rotterdam Study , 2017, Neurobiology of Aging.
[2] Keith L Black,et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. , 2017, JCI insight.
[3] Emanuele Trucco,et al. Lateral thinking – Interocular symmetry and asymmetry in neurovascular patterning, in health and disease , 2017, Progress in Retinal and Eye Research.
[4] M. Avilés-Trigueros,et al. Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension , 2017, Front. Neurosci..
[5] P. Visser,et al. Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis , 2017, Alzheimer's & dementia.
[6] Enrico Pellegrini,et al. The application of retinal fundus camera imaging in dementia: A systematic review , 2016, Alzheimer's & dementia.
[7] Chunbo Li,et al. Amyloid Plaques in Retina for Diagnosis in Alzheimer’s Patients: a Meta-Analysis , 2016, Front. Aging Neurosci..
[8] Kinpui Chan,et al. Optical Coherence Tomography in the UK Biobank Study – Rapid Automated Analysis of Retinal Thickness for Large Population-Based Studies , 2016, PloS one.
[9] K. Black,et al. Ocular indicators of Alzheimer’s: exploring disease in the retina , 2016, Acta Neuropathologica.
[10] Na Rae Kim,et al. Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease , 2016, PloS one.
[11] Louise Terry,et al. Automated Retinal Layer Segmentation Using Spectral Domain Optical Coherence Tomography: Evaluation of Inter-Session Repeatability and Agreement between Devices , 2016, PloS one.
[12] Pablo Villoslada,et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.
[13] M. Cordeiro,et al. Visual and Ocular Manifestations of Alzheimer’s Disease and Their Use as Biomarkers for Diagnosis and Progression , 2016, Front. Neurol..
[14] Nicholas G Strouthidis,et al. Spectral-Domain Optical Coherence Tomography Imaging in 67 321 Adults: Associations with Macular Thickness in the UK Biobank Study. , 2016, Ophthalmology.
[15] Milan Sonka,et al. Automated Segmentability Index for Layer Segmentation of Macular SD-OCT Images , 2016, Translational vision science & technology.
[16] Francesco Pierelli,et al. Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis , 2015, PloS one.
[17] Paloma Sobrado-Calvo,et al. Comparison of Retinal Nerve Fiber Layer Thinning and Retinal Ganglion Cell Loss After Optic Nerve Transection in Adult Albino Rats. , 2015, Investigative ophthalmology & visual science.
[18] T. Wong,et al. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy , 2015, Neuroscience Letters.
[19] Tien Yin Wong,et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[20] Aad van der Lugt,et al. Patterns of cognitive function in aging: the Rotterdam Study , 2014, European Journal of Epidemiology.
[21] Brad Fortune,et al. Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats. , 2014, Investigative ophthalmology & visual science.
[22] Giovanni Staurenghi,et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. , 2013, Investigative ophthalmology & visual science.
[23] A. Wimo,et al. The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.
[24] Axel Petzold,et al. The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.
[25] Keith L. Black,et al. Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment , 2012, Neurodegenerative Diseases.
[26] O. Franco,et al. The Rotterdam Study: 2012 objectives and design update , 2011, European Journal of Epidemiology.
[27] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[28] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[29] Daniel L. Farkas,et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model , 2011, NeuroImage.
[30] Monique M. B. Breteler,et al. The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.
[31] K. Ashe,et al. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. , 2008, Investigative ophthalmology & visual science.
[32] G. C. Román,et al. Vascular dementia , 1993, Neurology.
[33] Alfredo A. Sadun,et al. Retinal ganglion cell degeneration in Alzheimer's disease , 1989, Brain Research.
[34] C. Miller,et al. Optic-nerve degeneration in Alzheimer's disease. , 1986, The New England journal of medicine.
[35] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[36] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.